Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1745-6150
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure ; volume:16 ; number:1 ; day:18 ; month:1 ; year:2021 ; pages:1-15 ; date:12.2021
Biology direct ; 16, Heft 1 (18.1.2021), 1-15, 12.2021

Urheber
Liu, Anika
Walter, Moritz
Wright, Peter
Bartosik, Aleksandra
Dolciami, Daniela
Elbasir, Abdurrahman
Yang, Hongbin
Bender, Andreas
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13062-020-00285-0
URN
urn:nbn:de:101:1-2021030923014463146631
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:29 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Liu, Anika
  • Walter, Moritz
  • Wright, Peter
  • Bartosik, Aleksandra
  • Dolciami, Daniela
  • Elbasir, Abdurrahman
  • Yang, Hongbin
  • Bender, Andreas
  • SpringerLink (Online service)

Ähnliche Objekte (12)

The challenge of drug-induced liver injury (DILI)

Konferenzschrift | Kongress

The challenge of drug-induced liver injury (DILI)

Drug-Induced Liver Injury (DILI): A Major Challenge

Drug-Induced Liver Injury (DILI): A Major Challenge

Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)

Hochschulschrift

Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative

Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative

InterDILI: interpretable prediction of drug-induced liver injury through permutation feature importance and attention mechanism

InterDILI: interpretable prediction of drug-induced liver injury through permutation feature importance and attention mechanism

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Correction to: Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative

Correction to: Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative

A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI)

A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI)

Verbundene Objekte